Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Oren Livnat is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/11/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 05/31/2024 | XERS | Buy Now | Xeris Biopharma Holdings | $2.29 | 162.58% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | CARA | Buy Now | Cara Therapeutics | $0.64 | 459.96% | → $3.6 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $8.84 | 58.37% | $13 → $14 | Maintains | Buy | Get Alert |
| 05/13/2024 | TARS | Buy Now | Tarsus Pharmaceuticals | $33.18 | 83.85% | $57 → $61 | Maintains | Buy | Get Alert |
| 05/13/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $64.67 | 34.53% | $83 → $87 | Maintains | Buy | Get Alert |
| 05/09/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $15.29 | 76.59% | $25 → $27 | Maintains | Buy | Get Alert |
| 05/08/2024 | PCRX | Buy Now | Pacira BioSciences | $28.87 | 97.44% | → $57 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $110.47 | 81.05% | → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | ZVRA | Buy Now | Zevra Therapeutics | $4.56 | 228.95% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $110.47 | 81.05% | $204 → $200 | Maintains | Buy | Get Alert |
| 03/07/2024 | XERS | Buy Now | Xeris Biopharma Holdings | $2.29 | 162.58% | $5.5 → $6 | Maintains | Buy | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $15.29 | 63.51% | $21 → $25 | Maintains | Buy | Get Alert |
| 03/05/2024 | ZVRA | Buy Now | Zevra Therapeutics | $4.56 | 228.95% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2024 | PCRX | Buy Now | Pacira BioSciences | $28.87 | 97.44% | → $57 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $64.67 | 28.35% | $73 → $83 | Maintains | Buy | Get Alert |
| 03/01/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $8.84 | 47.06% | $12 → $13 | Maintains | Buy | Get Alert |
| 02/28/2024 | TARS | Buy Now | Tarsus Pharmaceuticals | $33.18 | 71.79% | $50 → $57 | Maintains | Buy | Get Alert |
| 01/04/2024 | MNKD | Buy Now | MannKind | $4.42 | 69.66% | → $7.5 | Reiterates | Buy → Buy | Get Alert |
| 12/28/2023 | ZVRA | Buy Now | Zevra Therapeutics | $4.56 | 228.95% | $10 → $15 | Maintains | Buy | Get Alert |
| 12/19/2023 | CARA | Buy Now | Cara Therapeutics | $0.64 | 288.86% | $7 → $2.5 | Maintains | Buy | Get Alert |
| 11/13/2023 | XERS | Buy Now | Xeris Biopharma Holdings | $2.29 | 140.7% | $6 → $5.5 | Maintains | Buy | Get Alert |
| 11/10/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $33.18 | 50.69% | $42 → $50 | Maintains | Buy | Get Alert |
| 11/06/2023 | PCRX | Buy Now | Pacira BioSciences | $28.87 | 97.44% | $63 → $57 | Maintains | Buy | Get Alert |
| 10/19/2023 | CARA | Buy Now | Cara Therapeutics | $0.64 | 988.82% | $15 → $7 | Maintains | Buy | Get Alert |
| 10/12/2023 | VRCA | Buy Now | Verrica Pharmaceuticals | $8.84 | 35.75% | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $64.67 | 12.89% | $60 → $73 | Maintains | Buy | Get Alert |
| 08/14/2023 | MNKD | Buy Now | MannKind | $4.42 | 69.66% | $7 → $7.5 | Maintains | Buy | Get Alert |
| 08/11/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $110.47 | 84.67% | → $204 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $33.18 | 26.58% | $50 → $42 | Maintains | Buy | Get Alert |
| 08/10/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $15.29 | 37.34% | → $21 | Reiterates | Buy → Buy | Get Alert |
